Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2010
12/08/2010EP2258697A1 Hydroxyquinoxalinecarboxamide derivative
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258402A2 Dried composition
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258364A1 Preventive and/or remedy for vascular diseases
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2257556A1 Prasugrel salts with improved properties
12/08/2010EP2257539A1 Substituted 4-hydroxypyrimidine-5-carboxamides
12/08/2010EP2257311A1 Conjugated factor viii molecules
12/08/2010EP2257170A1 Tetrahydrofuropyridones
12/08/2010EP2257169A1 Tetrahydrothieno pyridines
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1458759B1 Human antibodies against human glycoprotein vi and their use
12/08/2010EP1427750B1 Modified transferrin fusion proteins
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1897952B Neutrophilia inhibitor
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101906169A Process combination for preparing bletilla polysaccharide
12/08/2010CN101906147A Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine
12/08/2010CN101906146A Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine
12/08/2010CN101906145A Conjugate and a synthesis method of two Arg-Gly-Asp-Val chains and fatty alcohol chain through Lys, as well as application in medicine
12/08/2010CN101906144A Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof
12/08/2010CN101906143A Conjugate of two Arg-Gly-Asp chains and one fatty alcohol chain through Lys, synthesis and medicine application thereof
12/08/2010CN101906142A Carboline carboxylic acid-tetrapeptide conjugate and synthesis method as well as medical application thereof
12/08/2010CN101906141A Conjugates of one class of peptide chain and double fatty alcohol chains as well as preparation method and application thereof
12/08/2010CN101906140A Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof
12/08/2010CN101906139A Conjugate of peptide chain, Lys and aliphatic alcohol chain, preparation method and application thereof
12/08/2010CN101906137A Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof
12/08/2010CN101906136A Amino acid-(3,4-dyhydroxy-Phe)-Ser-Leu false peptide, and synthesizing method and application thereof
12/08/2010CN101906097A 1,3-dioxane compounds as well as synthesizing method and medical application thereof
12/08/2010CN101906085A Compound and composition for treating cardiovascular and cerebrovascular diseases and preparation method and use thereof
12/08/2010CN101904966A Chinese herbal medicine for curing metrorrhagia of young married woman
12/08/2010CN101904959A Medicament for treating hematochezia disease
12/08/2010CN101904954A Blood-enriching and heart-nourishing wine
12/08/2010CN101904939A Chinese herb medicine for treating senile metrorrhagia
12/08/2010CN101904926A Hematochezia dispelling wine
12/08/2010CN101904920A Oral traditional Chinese medicine for treating leucocytopenia
12/08/2010CN101904913A Extravasated blood pain removing agent
12/08/2010CN101904903A Lotus plumule extract and quality control method thereof
12/08/2010CN101904893A Angelica sinensis blood enriching capsule and preparation method thereof
12/08/2010CN101904856A Application of 1,6-diphosphofructose and derivative thereof in preparing animal medical health care products
12/08/2010CN101904848A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/08/2010CN101904841A Phenylphthalimide analog and its application for preparing diabetic macular edema drugs
12/08/2010CN101904833A Salvianic acid A medical composition and preparation method thereof
12/08/2010CN101904821A Quercetin nano freeze-dried powder and preparation method thereof
12/08/2010CN101904820A Quercetin nanosuspension freeze-drying composition and preparation method and application thereof
12/08/2010CN101597595B Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3
12/08/2010CN101401831B Xuesaitong extract and injection thereof
12/08/2010CN101367881B High-efficiency preparation method for glossy ganoderma polysaccharide
12/08/2010CN101365463B Antacid
12/08/2010CN101348490B Preparation of clopidogrel and salt thereof
12/08/2010CN101317916B Medicament for treating metrorrhagia and metrostaxis and preparation method thereof
12/08/2010CN101288767B Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
12/08/2010CN101264118B Preparation of cirsium japonicum root powder preparation and uses thereof
12/08/2010CN101249063B Calciparine/sodium salt nano oral preparation and preparation technique thereof
12/08/2010CN101089019B Polypeptides with antithrombotic activity and their prepn process and application
12/08/2010CN101077414B Medicine new use for liver hydrolysis-peptide
12/08/2010CN101066085B Health tea composition
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2404767C Bile secretion promoting composition containing a 15-keto prostaglandin
12/02/2010WO2010137939A1 Method for producing a nutraceutical composition and the nutraceutical produced by the method
12/02/2010WO2010137855A2 Multi-layer tablet comprising effervescent layer
12/02/2010WO2010137613A1 Solid preparation having improved storage stability
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136127A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
12/02/2010WO2010135854A1 Use of rlz-8 for the prevention or treatment of thrombocytopenia and a pharmaceutical composition comprising rlz-8
12/02/2010US20100305208 Gastric retention controlled drug delivery system
12/02/2010US20100305204 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305183 Method and composition for reducing reperfusion injury
12/02/2010US20100305154 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305133 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305111 Substituted piperidines
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305102 Heterocycle-substituted piperazino-dihydrothienopyrimidines
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305063 Water-Soluble Iron Carbohydrate Derivative Complexes, The Preparation Thereof, And Medicaments Comprising Them
12/02/2010US20100305051 Natriuretic activities
12/02/2010US20100305037 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100305022 Low molecular weight heparin composition and uses thereof
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303786 Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing Compounds
12/02/2010US20100303775 Generation of Genetically Corrected Disease-free Induced Pluripotent Stem Cells
12/02/2010DE102009022895A1 Substituierte Piperidine Substituted piperidines
12/02/2010DE102009022892A1 Substituierte Piperidine Substituted piperidines
12/02/2010CA2763351A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256138A1 Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 671